A PROSPECTIVE STUDY TO ASSESS THE INTERACTION BETWEEN PATIENT GENOTYPE AND ROSTAFUROXIN EFFECTS ON ARTERIAL BLOOD PRESSURE AND KIDNEY FUNCTION IN NEVER-TREATED HYPERTENSIVE TYPE 2 DIABETES PATIENTS (AN OPEN LABEL STUDY WITH BLINDED PATIENT GENOTYPE) [STUDIO DELL'INTERAZIONE TRA GENOTIPO ED EFFETTO DELLA ROSTAFUROXINA SU PRESSIONE ARTERIOSA E FUNZIONALITA' RENALE IN PAZIENTI CON DIABETE TIPO 2 ED IPERTENSIONE ARTERIOSA MAI TRATTATA]

Trial Profile

A PROSPECTIVE STUDY TO ASSESS THE INTERACTION BETWEEN PATIENT GENOTYPE AND ROSTAFUROXIN EFFECTS ON ARTERIAL BLOOD PRESSURE AND KIDNEY FUNCTION IN NEVER-TREATED HYPERTENSIVE TYPE 2 DIABETES PATIENTS (AN OPEN LABEL STUDY WITH BLINDED PATIENT GENOTYPE) [STUDIO DELL'INTERAZIONE TRA GENOTIPO ED EFFETTO DELLA ROSTAFUROXINA SU PRESSIONE ARTERIOSA E FUNZIONALITA' RENALE IN PAZIENTI CON DIABETE TIPO 2 ED IPERTENSIONE ARTERIOSA MAI TRATTATA]

Discontinued
Phase of Trial: Phase II

Latest Information Update: 26 Feb 2014

At a glance

  • Drugs Rostafuroxin (Primary)
  • Indications Hypertension in diabetes
  • Focus Pharmacodynamics; Therapeutic Use
  • Acronyms PAIR
  • Most Recent Events

    • 26 Feb 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top